On Monday, the head of the Centers for Disease Control and Prevention, Robert Redfield, praised surveillance testing programs, specifically mentioning those on some college and university campuses that test students once or twice weekly. “Don’t underestimate the value of strategic testing as part of a mitigation strategy to identify the asymptomatic individual and get them… Read More
In the US there has been a push to accept more transplant kidneys from hepatitis C viral (HCV) infected donors for hepatitis C negative recipients. A team, led by Miklos Z. Molnar, MD, PhD, Associate Professor of Medicine, University of Tennessee Health Science Center James D. Eason Transplant Institute, examined the association of HCV infected… Read More
Doctor Nick Hysmith, medical director of infection prevention at Le Bonheur Children’s Hospital, spoke with WMC Action News 5′s Joe Birch Tuesday about the COVID-19 vaccine rollout in Tennessee. Hysmith also serves on the Methodist Le Bonheur Vaccine Task Force and is a professor at the University of Tennessee Health Sciences Center.
The University of Tennessee Health Science Center is partnering with Regional One Health to offer a post-COVID-19 clinic to help people suffering with sometimes debilitating symptoms weeks and even months after their COVID-19 diagnosis. • December 15: WMC Action News 5 at 5:00PM • December 16: WMC Action News 5 at 4:30 AM • December… Read More
The Center for Control Disease and Prevention’s director said the new vaccine is the light at the end of the tunnel to this deadly pandemic but only if people take it. Director Dr. Robert Redfield believes the world needs a vaccination rate of more than 85 percent if we want to achieve herd immunity, which… Read More
If the coronavirus were just another cold or flu virus, herd immunity could probably be achieved at 70%. This virus is so much more contagious, Dr. Robert Redfield expects the world is looking at 85% to 90% “to shut this down.” “That’s my own personal speculation,” Redfield said in an hourlong Zoom conversation Monday, Dec.… Read More
As several COVID-19 vaccines inch closer to federal approval and mass distribution in the coming weeks, in the Mid-South Friday, local participants did their part in another vaccine trial now underway. St. Jude and the University of Tennessee Health Science Center recently opened a site for Johnson & Johnson’s Phase 3 trail of its COVID-19… Read More
A head official at the U.S. Centers for Disease Control and Prevention will join a virtual conversation on the coronavirus with the University of Tennessee Health Science Center. Dr. Robert Redfield will host the discussion on Zoom about the pandemic and public health response to the coronavirus.
